Werewolf Therapeutics, Inc.·4

Jan 6, 5:41 PM ET

HICKLIN DANIEL J 4

4 · Werewolf Therapeutics, Inc. · Filed Jan 6, 2025

Insider Transaction Report

Form 4
Period: 2025-01-02
HICKLIN DANIEL J
DirectorSee Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-02+592,690592,690 total
    Exercise: $1.56Exp: 2034-12-31Common Stock (592,690 underlying)
  • Award

    Stock Option (right to buy)

    2025-01-02+185,652185,652 total
    Exercise: $1.56From: 2027-01-02Exp: 2034-12-31Common Stock (185,652 underlying)
Footnotes (1)
  • [F1]The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4